about
The role of necrotic cell death in the pathogenesis of immune mediated nephropathies.Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis.17β estradiol regulates adhesion molecule expression in mesangial cells during glomerulonephritis.Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onsetSPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore.Immune-Mediated Nephropathy and Systemic Autoimmunity in Mice Does Not Require Receptor Interacting Protein Kinase 3 (RIPK3).Ca2+ signals regulate mitochondrial metabolism by stimulating CREB-mediated expression of the mitochondrial Ca2+ uniporter gene MCU.Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation.Differential regulation of cell death programs in males and females by Poly (ADP-Ribose) Polymerase-1 and 17β estradiolComparison of proteins expressed on secretory vesicle membranes and plasma membranes of human neutrophils.Biomarkers in connective tissue diseases.Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.The actin cytoskeleton regulates exocytosis of all neutrophil granule subsets.Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.Heat shock protein 27 regulates neutrophil chemotaxis and exocytosis through two independent mechanismsEpstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine modelAssociation of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals
P50
Q35142272-ADB53FF1-6028-4218-84D3-3707F9F5CF6CQ35192591-102D2CE1-D8B7-484A-A87D-FAFEE1462104Q35738559-7D746D46-3BC2-4764-A5C2-106AD14212A7Q36054583-97C1B097-4F60-4777-B581-DAA3FAB52577Q36118077-CC9FF933-F555-40AB-8392-1FB234056DB5Q36145022-C2512928-048B-4A89-B18B-102B79B6CFCCQ36490057-75234986-652B-45F5-9465-B727E693E3C7Q36786279-01394690-FDD9-4C60-88C2-203E93DEC428Q37148205-AEF656F8-0279-476B-8BA5-B935F0F25EE0Q38514110-E95C035B-2BB6-4AF1-A8B8-9D6126D9BC53Q47314399-7E9F398C-524D-4934-8958-4C927B376B75Q47565445-A65E6378-3BAF-4F52-BE84-3EB07C14136DQ52575996-5EA63DDE-6C85-4737-9E24-FA211E327F0EQ55080571-21874997-F63F-461E-A929-4EB904EEE243Q79718042-400CF887-E4B8-44A8-817D-DA144E63DABEQ90082632-27CEB26A-8F1F-4210-8BF1-F09919C965EFQ92882815-AF1D6B85-54D8-4D97-A6C6-E49A5C6A6658
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Neelakshi R Jog
@ast
Neelakshi R Jog
@en
Neelakshi R Jog
@es
Neelakshi R Jog
@nl
type
label
Neelakshi R Jog
@ast
Neelakshi R Jog
@en
Neelakshi R Jog
@es
Neelakshi R Jog
@nl
prefLabel
Neelakshi R Jog
@ast
Neelakshi R Jog
@en
Neelakshi R Jog
@es
Neelakshi R Jog
@nl
P106
P1153
15843356700
P31
P496
0000-0002-2477-2211